Findings

What do systematic reviews say?

4 questions · 4 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 1 · 25%GRADE not reported 0 · 0%Very low 3 · 75%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Closest answers

The findings closest to your search, judged one by one by TypeSafe's Jev model.

Direct match · question page
- BENZODIAZEPINES AS SOLE TREATMENT vs PLACEBO · Number of participants tranquillised at endpoint of the study (Desired sedation/tranquillisation)
  Benzodiazepines for schizophrenia 2012 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found
Related · question page
- BENZODIAZEPINES AS SOLE TREATMENT vs PLACEBO · No clinically important response to treatment ‐ short term
  Benzodiazepines for schizophrenia 2012 · Cochrane Headline outcomes only
  RR 0.67 [0.44, 1.02]
  6 studies · 382 participants
  Very low
Related · question page
- BENZODIAZEPINES AS SOLE TREATMENT vs PLACEBO · Leaving the study early due to any reason (overall acceptability of treatment)
  Benzodiazepines for schizophrenia 2012 · Cochrane Headline outcomes only
  RR 0.89 [0.57, 1.38]
  8 studies · 440 participants
  Very low
Related · question page
- BENZODIAZEPINES AS SOLE TREATMENT vs PLACEBO · Leaving the study early due to adverse effects (overall tolerability of treatment)
  Benzodiazepines for schizophrenia 2012 · Cochrane Headline outcomes only
  no estimate extracted
  4 studies · 161 participants
  Very low

BENZODIAZEPINES AS SOLE TREATMENT vs placebo

No clinically important response to treatment ‐ short term · patients with schizophrenia

It is very uncertain whether BENZODIAZEPINES AS SOLE TREATMENT changes no clinically important response to treatment ‐ short term compared with PLACEBO (very low certainty).

1 finding from 1 review

Benzodiazepines for schizophrenia 2012 · Cochrane Headline outcomes only
RR 0.67 [0.44, 1.02]
6 studies · 382 participants
Very low

BENZODIAZEPINES AS SOLE TREATMENT vs placebo

Unacceptability of treatment (drop-outs / leaving study early) · patients with schizophrenia

It is very uncertain whether BENZODIAZEPINES AS SOLE TREATMENT changes leaving the study early due to any reason (overall acceptability of… compared with PLACEBO (very low certainty).

1 finding from 1 review

Benzodiazepines for schizophrenia 2012 · Cochrane Headline outcomes only
RR 0.89 [0.57, 1.38]
8 studies · 440 participants
Very low

BENZODIAZEPINES AS SOLE TREATMENT vs placebo

Adverse effects (drop‐outs due to adverse effects4) · patients with schizophrenia

1 finding from 1 review

Benzodiazepines for schizophrenia 2012 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 161 participants
Very low

BENZODIAZEPINES AS SOLE TREATMENT vs placebo

Number of participants tranquillised at endpoint of the study (Desired sedation/tranquillisation) · patients with schizophrenia

The review found no eligible studies for this question.

1 finding from 1 review

Benzodiazepines for schizophrenia 2012 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found